IP Library Granted Patent US 8,394,597
Granted Patent B2
US 8,394,597 · App. 10/583,415 · Granted Mar 12, 2013

Endotoxin detection method

Inventors: Roman Meyer (Schmidmühlem, DE); Michael Schütz (Kareth-Lappersdorf, DE); Holger Grallert (Schriesheim, DE); Renate Grassl (Regensburg, DE); Stefan Miller (Regensburg, DE)
Assignee: Hyglos Invest GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,597
App. No.
10/583,415
Granted
Mar 12, 2013
Kind
B2
Abstract

The invention relates to a method for detecting endotoxins in a sample.

Claims (16)

1. A method for detection of endotoxin comprising the steps of:

a) contacting a sample containing endotoxins with a surface, subsequently

b) incubating of bacteriophage tail proteins with the endotoxin immobilised on the surface, and

c) detecting bacteriophage tail proteins by means of spectroscopic methods, ELISA, chemical or enzymatic detection reaction of endotoxins or cleaved-of endotoxin components, or by means of capacitance measurements.

2. The method according to claim 1 , further comprising after step b) and before step c) an additional step of separating said bound bacteriophage tail proteins from endotoxin.

3. The method according to claim 1 , wherein the surface is coated with bacteriophage tail proteins.

4. The method according to claim 1 , wherein the bacteriophage tail protein is a protein of the short bacteriophage tail fiber or a coat protein of bacteriophages without tail.

5. The method according to claim 1 , wherein the protein of the short bacteriophage tail fiber is selected from K3, T2, T4, Ox2, RB32-33, AR1, PP01 and RB69.

6. The method according to claim 4 , wherein the bacteriophage tail protein has a homology of at least 60% to T4p12 protein on the amino acid level.

7. The method according to claim 1 , wherein the bacteriophage tail proteins are modified.

8. The method according to claim 1 , wherein the bacteriophage tail proteins are covalently linked to enzymatically active proteins.

9. The method according to claim 1 , wherein the bacteriophage tail protein comprises a strep-tag or a his-tag.

10. The method according to claim 9 , wherein the tag comprises an amino acid sequence according to SEQ ID NOS 5, 6 or 7.

11. The method according to claim 9 , wherein the p12-protein of phage T4, K3, T2, Ox2, RB32-33, AR1, PPO1 or RB69 is used as bacteriophage tail protein.

12. The method according to claim 1 , wherein the Ca 2+ concentration is in the incubation 0.1 μM to 10 mM and/or the Mg 2+ concentration is 0.1 μM to 10 mM.

13. The method according to claim 1 , wherein marked endotoxin is displaced from the binding with a bacteriophage tail protein and wherein the marked endotoxin is detected subsequently.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2010
From: PROFOS AG
To: HYGLOS INVEST GMBH
Reel/Frame 023836/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2007
From: MEYER, ROMAN; SCHUTZ, MICHAEL; GRALLERT, HOLGER; GRASSL, RENATE; MILLER, STEFAN
To: PROFOS AG
Reel/Frame 018885/0370 →
Priority Claims (1)
DE 103 60 844 · Dec 20, 2003 · national
Continuity (1)
Related Publication 20110053188A1 · Mar 3, 2011